Kanker Payudara

Insuring the Trip: Navigating the Liability Landscape for FDA-Approved Psilocybin

• Treatment Innovations

Insuring the Trip: Navigating the Liability Landscape for FDA-Approved Psilocybin

Jia Lissa June 30, 2026

Fifty-five years after the Controlled Substances Act of 1970 relegated psilocybin to Schedule I status—placing it alongside...

Read More Read more about Insuring the Trip: Navigating the Liability Landscape for FDA-Approved Psilocybin

Rewiring the Brain: Could Microsurgery Be the Next Frontier in Alzheimer’s Treatment?

• Breast Cancer Surgery and Reconstruction

Rewiring the Brain: Could Microsurgery Be the Next Frontier in Alzheimer’s Treatment?

Dwi Wanna June 30, 2026

A groundbreaking medical hypothesis is gaining traction in the halls of international research institutions: the possibility that...

Read More Read more about Rewiring the Brain: Could Microsurgery Be the Next Frontier in Alzheimer’s Treatment?

Honoring the Architects of Global Wellness: WHO Recognizes Four Visionaries for Lifetime Achievements

• Breast Cancer Prevention and Lifestyle

Honoring the Architects of Global Wellness: WHO Recognizes Four Visionaries for Lifetime Achievements

Nana Muazin June 30, 2026

GENEVA, SWITZERLAND – At the Seventy-ninth World Health Assembly, a gathering defined by the urgent theme “Reshaping...

Read More Read more about Honoring the Architects of Global Wellness: WHO Recognizes Four Visionaries for Lifetime Achievements

Grounded in Hope: Navigating Childhood with a Parent’s Cancer Diagnosis

• Patient Advocacy and Support

Grounded in Hope: Navigating Childhood with a Parent’s Cancer Diagnosis

Basiran June 30, 2026

By Kelsey Mora, CCLS, LCPC, Chief Clinical Officer at Pickles Group Facing a cancer diagnosis is a...

Read More Read more about Grounded in Hope: Navigating Childhood with a Parent’s Cancer Diagnosis

Navigating the Unspoken: Understanding How Children Process a Parent’s Cancer Diagnosis

• Survivorship and Post-Treatment

Navigating the Unspoken: Understanding How Children Process a Parent’s Cancer Diagnosis

Evan Lee Salim June 30, 2026

By Kelsey Mora, CCLS, LCPC Chief Clinical Officer at Pickles Group For any parent, the moment of...

Read More Read more about Navigating the Unspoken: Understanding How Children Process a Parent’s Cancer Diagnosis

The End of the Diagnostic Odyssey: How AI is Revolutionizing Rare Disease Detection

• Genomics and Precision Medicine

The End of the Diagnostic Odyssey: How AI is Revolutionizing Rare Disease Detection

Evan Lee Salim June 30, 2026

For families navigating the complex world of rare diseases and developmental disorders, the "diagnostic odyssey"—a grueling, years-long...

Read More Read more about The End of the Diagnostic Odyssey: How AI is Revolutionizing Rare Disease Detection

Sanofi’s Cenrifki Challenges Traditional Metrics of Multiple Sclerosis Treatment Success

• Medical Research and Clinical Trials

Sanofi’s Cenrifki Challenges Traditional Metrics of Multiple Sclerosis Treatment Success

Ali Ikhwan June 30, 2026

New Analysis Suggests Focal Inflammatory Lesions May Not Signal Treatment Failure [City, Country] – [Date] – In...

Read More Read more about Sanofi’s Cenrifki Challenges Traditional Metrics of Multiple Sclerosis Treatment Success

A New Frontier in Myeloma Interception: Teclistamab Outperforms Standard Care in Phase II ImmunoPRISM Trial

• Clinical Oncology Education

A New Frontier in Myeloma Interception: Teclistamab Outperforms Standard Care in Phase II ImmunoPRISM Trial

Basiran June 30, 2026

In a landmark shift for the treatment of blood cancers, the Phase II ImmunoPRISM trial has unveiled...

Read More Read more about A New Frontier in Myeloma Interception: Teclistamab Outperforms Standard Care in Phase II ImmunoPRISM Trial

The New Economic Architecture of Generics: How MFN Pricing is Rewriting the Playbook for Pharma Finance

• Chemotherapy and Targeted Therapy

The New Economic Architecture of Generics: How MFN Pricing is Rewriting the Playbook for Pharma Finance

Layla Zulfa June 30, 2026

The U.S. pharmaceutical landscape is undergoing a structural metamorphosis. As regulatory pressure mounts to curb soaring healthcare...

Read More Read more about The New Economic Architecture of Generics: How MFN Pricing is Rewriting the Playbook for Pharma Finance

From Fear to Freedom: How One Woman’s BRCA2 Journey Redefined Genetic Empowerment

• Survivorship and Post-Treatment

From Fear to Freedom: How One Woman’s BRCA2 Journey Redefined Genetic Empowerment

Ali Ikhwan June 30, 2026

By Editorial Staff June 22, 2026 In the modern era of precision medicine, the discovery of a...

Read More Read more about From Fear to Freedom: How One Woman’s BRCA2 Journey Redefined Genetic Empowerment